The high cost of not funding stroke research: A comparison with heart disease and cancer

Lancet

Volumn 357, Issue 9268, 2001, Pages 1612-1616

  Rothwell, P M ^a  

^a Stroke Prevention Research Unit   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOMA; CLINICAL RESEARCH; COMPARATIVE STUDY; ECONOMIC ASPECT; FINANCIAL MANAGEMENT; HEART DISEASE; HUMAN; MORTALITY; NEGLECT; PRIORITY JOURNAL; REVIEW; SOCIAL WELFARE; STROKE;

EID: 0035912519     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)04730-9     Document Type: Note

References (24)

1. Sudlow CLM, Warlow CP, for the International Stroke Incidence Collaboration. Comparable studies of the incidence of stroke and its pathological types: results from an international collaboration. Stroke 1997; 28: 491-99.
2. MacDonald BK, Cockerell OC, Sander JWAS, Shorvon SD. The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the UK. Brain. 123:2000;665-676.
3. Bonita R. Epidemiology of stroke. Lancet. 339:1992;342-344.
4. Murray CJL, Lopez AD. The Global Burden of Disease: a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020. Boston: Harvard University Press; 1996.
5. Bamford J, Sandercock P, Dennis M, Burn J, Warlow C. A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project 1981-1986: incidence, case fatality and overall outcome at one year of cerebral infarction, primary intracerebral haemorrhage and subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry. 53:1990;16-22.
6. Volmink JA, Newton JN, Hicks NR, Sleight P, Fowler GH, Neil HAW, on behalf of the Oxford Myocardial Infarction Incidence Study Group. Coronary event and case fatality rates in an English population: results of the Oxford myocardial infarction incidence study. Heart 1998; 80: 40-44.
7. Wolfe CDA. The impact of stroke. British Medical Bulletin. 56:2000;275-286.
8. Stroke Care: reducing the burden of disease. The Stroke Association. London: 1998.
9. Coronary Heart Disease Statistics: British Heart Foundation Statistics Database 1998. London: British Heart Foundation; 1998.
10. Stegmayr B, Asplund K. Exploring the declining case fatality in acute stroke Population-based observations in the northern Sweden MONICA Project. J Intern Med. 240:1996;143-149.
11. Menken M, Munsat TL, Toole JF. The Global Burden of Disease Study. Implications for neurology. Arch Neurol. 57:2000;418-420.
12. Janca A, Prilipko L, Costa e Silva JA. The WHOs global initiative on neurology and public health. J Neurol Sci. 145:1997;1-2.
13. Traystman RJ, Hademenos G. Increased funding for stroke research. Stroke. 30:1999;1147.
14. Field Review. Neuroprotection in acute brain injury after trauma and stroke: from preclinical research to clinical trials. London: Medical Research Council; 1999.
15. MRC Annual Report 1998-1999. London: Medical Research Council; 1999.
16. Medical Research Council: launchpad for 21st century health. London: Medical Research Council; 1998.
17. Gross CP, Anderson GF, Powe NR. The relation between funding by the National Institutes of Health and the burden of disease. N Engl J Med. 340:1999;1881-1887.
18. Toole JF, Toole WW. Federal funding for research in strokeand trauma - a clinical investigator's viewpoint. Stroke. 15:1984;168-171.
19. Goldstein M. Federal funding for research in stroke and trauma-a clinical investigator's viewpoint. Stroke. 15:1984;172-173.
20. Prospective Studies Collaboration. Cholesterol, diastolic BP, and stroke: 13 000 strokes in 450 000 people in 45 cohorts. Lancet 1995; 346: 1647-53.
21. Wessely S. Peer review of grant applications: what do we know? Lancet. 352:1998;301-305.
22. British Heart Foundation. Annual Report of the Medical Division 1998-1999. London: British Heart Foundation; 1999.
23. Imperial Cancer Research Fund. Scientific Report 1999. London: Imperial Cancer Research Fund; 1999.
24. Imperial Cancer Research Fund. Annual Reports and Accounts 1999. London: Imperial Cancer Research Fund; 1999.